U.S. House · CO-1Bioguide ID D000197
Diana DeGette
U.S. Representative for Colorado’s 1st district
Democrat
In Congress since1997
Term endsJan 3, 2027
119th Congress, two-year term
On the record
- Yes
- 281
- No
- 380
- Present
- 1
- Did not vote
- 11
- Speaker election
- 1
Missed 1.6% of roll calls. Chamber median 1.9%.
The full voting record50%Chamber median 98%100%
Counts roll calls where most Democrats and most Republicans voted differently, leaving out procedural votes.
How we count- Introduced
- 16
- Passed committee
- 1
- Passed a chamber
- 1
- Became law
- 0
- Individuals
- $688K
- PACs
- $1.0M
- Party
- $20
- Other
- $8K
From FEC filings, Voteview roll calls and Congress.gov.
Democrat. In Congress since 1997, 15 terms in total.
Following saves DeGette to your list, which Chamber & Street keeps on its server, linked to a cookie on this browser and not to your name or email. Email alerts will come with constituent verification.
Bills sponsored, 119th Congress
Bills and resolutions where DeGette is the primary sponsor. Most bills never leave committee; that is normal for every member. Source: Congress.gov, last updated Oct 29, 2026.
- Sponsored
- 16
- Passed committee
- 1
- Passed a chamber
- 1
- Became law
- 0
6 of 16 have at least one cosponsor from the other party.
INSULIN Act of 2026
Introduced Sep 2, 2026. 19 cosponsors, 3 from the other party. H.R. 10227 on Congress.gov(opens in a new tab)
Introduced
Medicare Advantage Cost Transparency Act
Introduced Jun 23, 2026. 1 cosponsor, 1 from the other party. H.R. 9392 on Congress.gov(opens in a new tab)
Introduced
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.